The Spanish register (BIOBADASER) found that anti-TNF therapy is associated with higher susceptibility to severe infections in rheumatoid arthritis (RA) patients in particular during the first 6 months of treatment [3]. This evidence concerns the gene TNF and rheumatoid arthritis.